MENU
RGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
REGENXBIO (RGNX) Earnings Date & Reports
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
RGNX is expected to report earnings to fall 381.40% to -121 cents per share on November 11
Q3'26
Est.
$-1.21
Q2'26
Beat
by $0.18
Q1'26
Missed
by $0.38
Q4'25
Missed
by $0.58
Q3'25
Beat
by $0.10
The last earnings report on August 06 showed earnings per share of 43 cents, beating the estimate of 25 cents. With 766.05K shares outstanding, the current market capitalization sits at 575.64M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of gene therapy treatments
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
371
Web
https://www.regenxbio.com